Reaction Behavior of [1,3-Diethyl-4,5-diphenyl-1


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
22 06 2023
Historique:
medline: 23 6 2023
pubmed: 9 6 2023
entrez: 9 6 2023
Statut: ppublish

Résumé

The reactivities of halido[1,3-diethyl-4,5-diphenyl-1

Identifiants

pubmed: 37294951
doi: 10.1021/acs.jmedchem.3c00589
pmc: PMC10291549
doi:

Substances chimiques

Antineoplastic Agents 0
Biphenyl Compounds 0
diphenyl 2L9GJK6MGN
Gold 7440-57-5
Hydrocarbons, Halogenated 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8238-8250

Références

Mol Cancer Ther. 2008 Mar;7(3):670-8
pubmed: 18347152
J Med Chem. 2002 Aug 1;45(16):3356-65
pubmed: 12139447
Molecules. 2020 Nov 20;25(22):
pubmed: 33233711
Br J Rheumatol. 1997 May;36(5):560-72
pubmed: 9189058
Arch Pharm (Weinheim). 2002 Dec;335(10):463-71
pubmed: 12506394
Chem Commun (Camb). 2019 Aug 29;55(71):10627-10630
pubmed: 31429450
Dalton Trans. 2022 Jan 25;51(4):1395-1406
pubmed: 34989741
Eur J Med Chem. 2018 Feb 25;146:709-746
pubmed: 29407992
J Med Chem. 2020 Sep 10;63(17):9197-9211
pubmed: 32787098
Cancer Treat Rev. 1990 Sep;17(2-3):203-8
pubmed: 2272034
Molecules. 2020 Jul 30;25(15):
pubmed: 32751607
Integr Med (Encinitas). 2014 Feb;13(1):8-12
pubmed: 26770075
ChemMedChem. 2020 Jun 17;15(12):1067-1077
pubmed: 32298535
Inorg Chem. 2021 Jun 21;60(12):8546-8553
pubmed: 34097405
Pharmaceutics. 2023 Jan 31;15(2):
pubmed: 36839788
J Biol Inorg Chem. 2022 Dec;27(8):691-694
pubmed: 36315287
Dalton Trans. 2016 Oct 4;45(39):15481-15491
pubmed: 27722449
Discov Oncol. 2021 Oct 20;12(1):42
pubmed: 35201489
Chem Soc Rev. 2019 Jan 21;48(2):447-462
pubmed: 30474097
Inorg Chem. 2014 Feb 17;53(4):2296-303
pubmed: 24499428
Dalton Trans. 2020 May 7;49(17):5471-5481
pubmed: 32255443
Arch Pharm (Weinheim). 2007 Mar;340(3):117-26
pubmed: 17315259
Oncotarget. 2014 Aug 30;5(16):7027-39
pubmed: 25216521
Chem Soc Rev. 2022 Jul 4;51(13):5518-5556
pubmed: 35699475
Molecules. 2022 Oct 01;27(19):
pubmed: 36235023
Chem Asian J. 2020 Sep 1;15(17):2754-2762
pubmed: 32592289
J Med Chem. 2011 Dec 22;54(24):8605-15
pubmed: 22091836
Eur J Med Chem. 2020 Jun 1;195:112258
pubmed: 32272420
J Clin Invest. 1991 Mar;87(3):772-7
pubmed: 1999494
Oncotarget. 2017 Oct 9;8(56):96062-96078
pubmed: 29221187
Chem Soc Rev. 2015 Dec 21;44(24):8786-801
pubmed: 25868756
Eur J Med Chem. 2021 Apr 15;216:113285
pubmed: 33662676
Mol Aspects Med. 2009 Feb-Apr;30(1-2):1-12
pubmed: 18796312
J Med Chem. 2020 Dec 24;63(24):15279-15307
pubmed: 33325699
J Med Chem. 2012 Apr 26;55(8):3713-24
pubmed: 22424185
Inorg Chem. 2020 Oct 19;59(20):15312-15323
pubmed: 33006470
Dalton Trans. 2014 Mar 21;43(11):4209-19
pubmed: 24225667
Drug Resist Updat. 2021 Sep;58:100778
pubmed: 34403910
Dalton Trans. 2021 Mar 28;50(12):4270-4279
pubmed: 33688890
Eur J Med Chem. 2020 Jan 1;185:111748
pubmed: 31648125
Future Med Chem. 2019 Jan;11(2):119-135
pubmed: 30644327

Auteurs

Paul Kapitza (P)

Department of Pharmaceutical Chemistry, Institute of Pharmacy, Center for Molecular Bioscience Innsbruck, University of Innsbruck, Innrain 80/82, Innsbruck A-6020, Austria.

Amelie Scherfler (A)

Department of Pharmaceutical Chemistry, Institute of Pharmacy, Center for Molecular Bioscience Innsbruck, University of Innsbruck, Innrain 80/82, Innsbruck A-6020, Austria.

Stefan Salcher (S)

Department of Internal Medicine V, Haematology & Oncology, Medical University Innsbruck, Anichstrasse 35, Innsbruck A-6020, Austria.

Sieghart Sopper (S)

Department of Internal Medicine V, Haematology & Oncology, Medical University Innsbruck, Anichstrasse 35, Innsbruck A-6020, Austria.

Monika Cziferszky (M)

Department of Pharmaceutical Chemistry, Institute of Pharmacy, Center for Molecular Bioscience Innsbruck, University of Innsbruck, Innrain 80/82, Innsbruck A-6020, Austria.

Klaus Wurst (K)

Department of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innrain 80/82, Innsbruck A-6020, Austria.

Ronald Gust (R)

Department of Pharmaceutical Chemistry, Institute of Pharmacy, Center for Molecular Bioscience Innsbruck, University of Innsbruck, Innrain 80/82, Innsbruck A-6020, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs
Humans Male Female Health Knowledge, Attitudes, Practice Middle Aged
Humans Hyaluronic Acid Osteoarthritis, Hip Female Middle Aged
Humans Neoplasms Male Female Middle Aged

Classifications MeSH